tiprankstipranks
Blurbs

Analysts Conflicted on These Services Names: Exelixis (EXEL) and Cineplex (OtherCPXGF)

Analysts have been eager to weigh in on the Services sector with new ratings on Exelixis (EXELResearch Report) and Cineplex (CPXGFResearch Report).

Exelixis (EXEL)

BMO Capital analyst Etzer Darout maintained a Buy rating on Exelixis today and set a price target of $28.00. The company’s shares closed last Wednesday at $17.49.

According to TipRanks.com, Darout is a 4-star analyst with an average return of 12.9% and a 42.1% success rate. Darout covers the Healthcare sector, focusing on stocks such as Arvinas Holding Company, Foghorn Therapeutics, and Y-Mabs Therapeutics.

Currently, the analyst consensus on Exelixis is a Strong Buy with an average price target of $25.80, which is a 49.2% upside from current levels. In a report issued on January 26, Credit Suisse also initiated coverage with a Buy rating on the stock with a $29.00 price target.

See the top stocks recommended by analysts >>

Cineplex (CPXGF)

In a report released today, Tim Casey from BMO Capital maintained a Hold rating on Cineplex, with a price target of C$12.00. The company’s shares closed last Tuesday at $6.66.

According to TipRanks.com, Casey is a 5-star analyst with an average return of 10.8% and a 69.2% success rate. Casey covers the Technology sector, focusing on stocks such as Rogers Communication, Shaw Communications, and Quebecor.

Cineplex has an analyst consensus of Strong Buy, with a price target consensus of $9.11.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on EXEL:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles